Zhiwei Hu

No ORCID on file · 6 papers in corpus · active 2010-2020

Study types

  • other 4
  • article 1
  • erratum 1

Condition tags

  • endometriosis 6
  • infertility 1
erratum 2020
Reproductive biology ·doi:10.1016/j.repbio.2020.08.005
article 2018
Reproductive biology ·doi:10.1016/j.repbio.2018.01.009
other 2018
Antibodies (Basel, Switzerland) ·doi:10.3390/antib7010008

Accumulating evidence suggests that tissue factor (TF) is selectively expressed in pathological angiogenesis-dependent as well as macrophage-associated human diseases. Pathological angiogenesis, the formation of neovasculature, is involved …

other 2017
Angiogenesis ·doi:10.1007/s10456-016-9530-9

Identification of target molecules specific for angiogenic vascular endothelial cells (VEC), the inner layer of pathological neovasculature, is critical for discovery and development of neovascular-targeting therapy for angiogenesis-depende…

other 2010
BMC immunology ·doi:10.1186/1471-2172-11-49

BACKGROUND: Icon is a novel, dual neovascular- and cancer cell-targeting immunotherapeutic agent and has shown efficacy in the treatment of cancer, wet form macular degeneration and endometriosis. However, its underlying mechanism remains t…

other 2010
The American journal of pathology ·doi:10.2353/ajpath.2010.090757

Endometriosis is a major cause of chronic pain, infertility, medical and surgical interventions, and health care expenditures. Tissue factor (TF), the primary initiator of coagulation and a modulator of angiogenesis, is not normally express…